WAYPAUR
Live / Registered — Registered (as of 05 Nov 2024)
What this means for you
Registered since 05 Nov 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Nov 2030: the §71 affidavit of use).
Record
- Serial number
- 79389605
- Registration number
- 7554433
- Mark type
- Word mark
- Filed
- 11 Dec 2023
- Published for opposition
- 20 Aug 2024
- Registered
- 05 Nov 2024
- Next maintenance filing
- §71 affidavit of use, due by 05 Nov 2030 (grace period to 05 May 2031)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of cardiovascular diseases
Owner
- Novo Nordisk A/S, DK
- Novo Nordisk A/S, DK
- Novo Nordisk A/S, DK
Prosecution history
- 01 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 14 Jul 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 14 Jul 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 05 Dec 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION
- 31 Jul 2024 — NOTICE OF PUBLICATION
- 11 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jul 2024 — ASSIGNED TO EXAMINER
- 27 Feb 2024 — APPLICATION FILING RECEIPT MAILED
- 21 Feb 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Feb 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB